Dear CARRA Members, Friends & Colleagues, The Scientific Advisory Committee (SAC) held it’s first full meeting in early September to discuss the organizational approach to developing and updating Consensus Treatment Plans (CTPs). CTPs standardize heterogeneous approaches to treatment and are a key element of Comparative Effectiveness Research that addresses important questions about how to effectively …
Use of Extrapolation to Support Regulatory Decision-Making Discussed (Washington, DC – August 4, 2023) – Findings from a recent stakeholder workshop on the development of therapeutics for polyarticular JIA (pJIA) were published online in the April 27, 2023 issue of Arthritis & Rheumatology. The report, “Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis (pcJIA): Extrapolation, …
Dear CARRA Members, Friends & Colleagues, It’s been over three months since we were together in New Orleans to carry on the important work that all of you do for CARRA. Thank you! I still reflect on the joy and happiness that a career in medicine has brought me, as was so eloquently articulated by …
The Arthritis Foundation and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) announce the recipients of almost $1.2 million in research funding for pediatric rheumatic diseases. Read the full press release at arthritis.org.
Dear Friends, I am delighted to have Mr. Mathieu Nelessen on board as CARRA’s new Chief Executive Officer (CEO)! Mathieu was selected by a CARRA CEO task force after a 3-month nationwide search and started with our organization on January 9th. Mathieu brings extensive leadership experience from many years at the American Red Cross,where he …
WASHINGTON, DC, December 6, 2022 – The Childhood Arthritis and Rheumatology Research Alliance, also known as CARRA, announced the appointment of Mathieu Nelessen as Chief Executive Officer, effective January 9, 2023. The CARRA Board of Directors unanimously approved the recommendation of Mr. Nelessen by a CARRA CEO search task force, which led a three-month nationwide …
Lupus Advocacy Efforts Drive Research Funding for the CARRA Registry. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) announced that the U.S. Centers for Disease Control and Prevention (CDC) awarded a 5-year $4.4 million grant to a team of North American lupus experts to advance critical research on childhood lupus through the CARRA Registry. Read …
Dear Friends, As I take on the role of CARRA President, I am reminded of a quote from Bill Gates: “Surround yourself with people who challenge you, teach you,and push you to be your best self.” With a few more ingredients, that’s a pretty good recipe for academic success,forming the environment in which most of …
Arthritis Foundation and CARRA Fund $1.1+ Million for Childhood Rheumatic Disease Research The Arthritis Foundation and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) announce more than $1.1 million in research funding for childhood rheumatic diseases, including juvenile idiopathic arthritis. Read the full press release at arthritis.org
CARRA announced the hiring of Interim CEO Larry Hausner on January 28, 2022. We recently visited with Larry to learn a little more about his leadership experiences and how he will support CARRA’s journey throughout 2022. Q: Please share with CARRA stakeholders and followers a little about your background. Larry: For most of the past …